Incidence of early loss of pregnancy, N Engl J Med, vol.319, pp.189-94, 1988. ,
Risk of preeclampsia in first and subsequent pregnancies: prospective cohort study, BMJ, vol.338, 2009. ,
Circulating angiogenic factors and the risk of preeclampsia, N Engl J Med, vol.350, pp.672-83, 2004. ,
Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?, Biochem Soc Trans, vol.37, pp.1237-1279, 2009. ,
New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications, Thromb Res, vol.127, issue.3, pp.72-77, 2011. ,
Development of resistance to activated protein C during pregnancy, Br J Haematol, vol.90, pp.725-732, 1995. ,
Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy, Thromb Haemost, vol.79, pp.1166-70, 1998. ,
Activation of coagulation in amniotic fluid during normal human pregnancy, Thromb Res, vol.128, pp.490-495, 2011. ,
Tissue factor and its natural inhibitor in pre-eclampsia and SGA, J Matern Fetal Neonatal Med, vol.21, pp.855-69, 2008. ,
Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight, Lancet, vol.353, pp.292-295, 1999. ,
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury, Blood, vol.110, pp.2423-2454, 2007. ,
The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis, Thromb Haemost, vol.91, pp.700-711, 2004. ,
Thrombophilia in pregnancy: a systematic review, Br J Haematol, vol.132, pp.171-96, 2006. ,
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies, PLoS Med, vol.7, 2010. ,
Genetic risk factors for placental abruption: a HuGE review and metaanalysis, Epidemiology, vol.19, pp.309-332, 2008. ,
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study, J Thromb Haemost, vol.12, pp.469-78, 2014. ,
Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells, Blood, vol.107, pp.3173-80, 2006. ,
Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis, Thromb Haemost, vol.92, pp.776-86, 2004. ,
Apoptosis and its role in the trophoblast, Am J Obstet Gynecol, vol.195, pp.29-39, 2006. ,
Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment, J Thromb Haemost, vol.3, pp.2355-2362, 2005. ,
Microvesicles of women with gestational hypertension and preeclampsia affect human trophoblast fate and endothelial function, Hypertension, vol.62, pp.893-901, 2013. ,
Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications, J Thromb Haemost, vol.7, pp.1047-50, 2009. ,
Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles, J Immunol, vol.178, pp.5949-56, 2007. ,
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy, Blood, vol.106, pp.401-408, 2005. ,
Low-molecularweight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder, Blood, vol.103, pp.3695-3704, 2004. ,
Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study, J Thromb Haemost, vol.3, pp.227-236, 2005. ,
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages, Fertil Steril, vol.86, pp.362-368, 2006. ,
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecularweight heparin and low-dose aspirin in women with recurrent miscarriage, Blood, vol.115, pp.4162-4169, 2010. ,
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage, N Engl J Med, vol.362, pp.1586-96, 2010. ,
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial, J Thromb Haemost, vol.7, pp.58-64, 2009. ,
Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial, Thromb Haemost, vol.104, pp.771-780, 2010. ,
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial, Blood, vol.119, pp.3269-75, 2012. ,
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study, Blood, vol.119, pp.2624-2656, 2012. ,
Lowmolecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUITRCT, J Thromb Haemost, vol.10, pp.64-72, 2012. ,
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction, Cochrane Database Syst Rev, vol.7, p.6780, 2013. ,
Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications, Blood, vol.123, pp.822-830, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00935578
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial, Lancet, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01258557